SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326110-24-000040
Filing Date
2024-04-23
Accepted
2024-04-23 06:17:01
Documents
15
Period of Report
2024-04-22
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibrx-20240422.htm   iXBRL 8-K 33565
2 EX-99.1 ibrx-2024422x8kexhibit991.htm EX-99.1 31326
6 ib_logoxfinalxcolorx02x2021.jpg GRAPHIC 231252
  Complete submission text file 0001326110-24-000040.txt   518695

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20240422.xsd EX-101.SCH 1926
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20240422_lab.xml EX-101.LAB 21876
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20240422_pre.xml EX-101.PRE 12528
18 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20240422_htm.xml XML 2718
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 24862617
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)